Similar articles

• A case of indomethacin toxicity: the drug information network and its benefits in therapy.

  Bainbridge CV, Ruger JR. Bainbridge CV, et al. Drug Inf J. 1979 Jan-Jun;13(1):35-40. doi: 10.1177/009286157901300110. Drug Inf J. 1979. PMID: 10242951 No abstract available.
• The structure and function of a clinical pharmacology consulting service.

  Spector R, Heller A, Johnson MW. Spector R, et al. J Clin Pharmacol. 1979 May-Jun;19(5-6):257-60. doi: 10.1002/j.1552-4604.1979.tb02478.x. J Clin Pharmacol. 1979. PMID: 469021 No abstract available.
• Initial experience of clinical pharmacology and clinical pharmacy interactions in a clinical pharmacokinetics consultation service.

  Taylor JW, McLean AJ, Leonard RG, Ludden TM, Clibon U, du Souich BP, Harris SC, Lalka D, Talbert RL, Vicuna N, Walton CA, McNay JL. Taylor JW, et al. J Clin Pharmacol. 1979 Jan;19(1):1-7. doi: 10.1002/j.1552-4604.1979.tb01610.x. J Clin Pharmacol. 1979. PMID: 762251 No abstract available.
• Methods of monitoring adverse reactions to drugs.

  Venulet J. Venulet J. Prog Drug Res. 1977;21:231-92. doi: 10.1007/978-3-0348-7098-6_3. Prog Drug Res. 1977. PMID: 339270 Review. No abstract available.
• Ways to minimize adverse drug reactions. Individualized doses and common sense are key.

  Cohen JS. Cohen JS. Postgrad Med. 1999 Sep;106(3):163-8, 171-2. doi: 10.3810/pgm.1999.09.688. Postgrad Med. 1999. PMID: 10494273 Review.